Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  • Sign In
    Sign in below to access your subscription for full content
    INDIVIDUAL SIGN IN
    Sign In|Set Up Account
    You will be directed to acponline.org to register and create your Annals account
    INSTITUTIONAL SIGN IN
    Open Athens|Shibboleth|Log In
    Annals of Internal Medicine
    SUBSCRIBE
    Subscribe to Annals of Internal Medicine.
    You will be directed to acponline.org to complete your purchase.
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Articles |7 June 2005

Gulf War Veterans' Health: Medical Evaluation of a U.S. Cohort Free

Seth A. Eisen, MD; Han K. Kang, DrPH; Frances M. Murphy, MD; Melvin S. Blanchard, MD; Domenic J. Reda, PhD; William G. Henderson, PhD; Rosemary Toomey, PhD; Leila W. Jackson, PhD; Renee Alpern, MS; Becky J. Parks, MD; Nancy Klimas, MD; Coleen Hall, MS; Hon S. Pak, MD; Joyce Hunter, MSN; Joel Karlinsky, MD; Michael J. Battistone, MD; Michael J. Lyons, PhD; and the Gulf War Study Participating Investigators*

Seth A. Eisen, MD
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Han K. Kang, DrPH
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Frances M. Murphy, MD
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Melvin S. Blanchard, MD
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Domenic J. Reda, PhD
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

William G. Henderson, PhD
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Rosemary Toomey, PhD
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Leila W. Jackson, PhD
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Renee Alpern, MS
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Becky J. Parks, MD
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Nancy Klimas, MD
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Coleen Hall, MS
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Hon S. Pak, MD
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Joyce Hunter, MSN
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Joel Karlinsky, MD
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Michael J. Battistone, MD
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

Michael J. Lyons, PhD
From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

and the Gulf War Study Participating Investigators*

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
  • From Veterans Affairs Medical Center, Washington University School of Medicine, and Saint Louis University, St. Louis, Missouri; Veterans Health Administration, Environmental Epidemiology Service, U.S. Department of Veterans Affairs, and Uniformed Services University of the Health Sciences, Washington, DC; Cooperative Studies Program Coordinating Center, Hines Veterans Affairs Hospital, Hines, Illinois; Brockton Veterans Affairs Medical Center, Brockton, Massachusetts; Harvard Medical School, Massachusetts Mental Health Center, Harvard Institute of Psychiatric Epidemiology and Genetics, Veterans Affairs Medical Center, and Boston University School of Medicine, Boston, Massachusetts; Miami Veterans Affairs Medical Center and University of Miami, Miami, Florida; Brooke Army Medical Center, Fort Sam Houston, Texas; and Veterans Affairs Salt Lake City Health Care System and University of Utah Health Sciences Center, Salt Lake City, Utah.

    Grant Support: By the Cooperative Studies Program of the U.S. Department of Veterans Affairs Office of Research and Development.

    Potential Financial Conflicts of Interest: None disclosed.

    Requests for Single Reprints: Seth A. Eisen, MD, MSc, St. Louis Veterans Affairs Medical Center (151 JC), 915 North Grand Avenue, St. Louis, MO 63106; e-mail, seth.eisen@med.va.gov.

    Current Author Addresses: Drs. Eisen and Blanchard: St. Louis Veterans Affairs Medical Center (151 JC), 915 North Grand Boulevard, St. Louis, MO 63106.

    Dr. Kang: U.S. Department of Veterans Affairs, 1722 I Street, Washington, DC 20006.

    Dr. Murphy: U.S. Department of Veterans Affairs, 811 Vermont Avenue NW, Washington, DC 20420.

    Dr. Reda, Ms. Alpern, and Ms. Hall: Hines Veterans Affairs Hospital, CSPCC (151-K), PO Box 5000, Hines, IL 60141.

    Dr. Henderson: University of Colorado Health Care Outcomes Program, Mail Stop F-443, PO Box 6508, Aurora, CO 80045-0508.

    Dr. Toomey: Boston University, 648 Beacon Street, 6th Floor, Boston, MA 02215.

    Dr. Jackson: Department of Epidemiology, John Hopkins University Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205.

    Dr. Parks: Department of Neurology, Washington University School of Medicine, 660 South Euclid, St. Louis, MO 63110.

    Dr. Klimas: Miami Veterans Affairs Medical Center, 1201 NW 16th Street, (111-I), Miami, FL 33125.

    Dr. Pak: Wilford Hall Air Force Medical Center, 2200 Bergquist Drive, Lackland AFB, TX 78236.

    Ms. Hunter: Deaconess College of Nursing, 6150 Oakland Avenue, St. Louis, MO 63139.

    Dr. Karlinsky: Veterans Affairs Boston Healthcare System, West Roxbury Campus, 1400 VFW Parkway, West Roxbury, MA 02132.

    Dr. Battistone: Salt Lake City Veterans Affairs Medical Center, 500 Foothill Drive, Salt Lake City, UT 84148.

    Dr. Lyons: Boston University, 648 Beacon Street, 2nd Floor, Boston, MA 02215.

    Author Contributions: Conception and design: S.A. Eisen, H.K. Kang, F.M. Murphy, M.S. Blanchard, D.J. Reda, W.G. Henderson, B.J. Parks, H.S. Pak, M.J. Lyons.

    Analysis and interpretation of the data: S.A. Eisen, H.K. Kang, F.M. Murphy, M.S. Blanchard, D.J. Reda, W.G. Henderson, R. Toomey, L.W. Jackson, R. Alpern, B.J. Parks, N. Klimas, C. Hall, H.S. Pak, J. Karlinsky, M.J. Battistone.

    Drafting of the article: S.A. Eisen, F.M. Murphy, M.S. Blanchard, L.W. Jackson, R. Alpern, J. Karlinsky.

    Critical revision of the article for important intellectual content: S.A. Eisen, F.M. Murphy, M.S. Blanchard, D.J. Reda, W.G. Henderson, R. Toomey, L.W. Jackson, N. Klimas, H.S. Pak, J. Karlinsky, M.J. Battistone, M.J. Lyons.

    Final approval of the article: S.A. Eisen, F.M. Murphy, M.S. Blanchard, D.J. Reda, W.G. Henderson, R. Toomey, L.W. Jackson, R. Alpern, N. Klimas, H.S. Pak, J. Hunter, J. Karlinsky, M.J. Battistone, M.J. Lyons.

    Provision of study materials or patients: S.A. Eisen, N. Klimas, J. Hunter, M.J. Battistone.

    Statistical expertise: S.A. Eisen, D.J. Reda, W.G. Henderson, R. Alpern.

    Obtaining of funding: S.A. Eisen, H.K. Kang, F.M. Murphy, W.G. Henderson.

    Administrative, technical, or logistic support: S.A. Eisen, H.K. Kang, M.S. Blanchard, D.J. Reda, W.G. Henderson, L.W. Jackson, J. Hunter, M.J. Battistone.

    Collection and assembly of data: S.A. Eisen, H.K. Kang, R. Toomey, B.J. Parks, J. Hunter, J. Karlinsky, M.J. Battistone.

×
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • FULL ARTICLE
  • FULL ARTICLE
    • Abstract
    • Editors’ Notes
    • Methods
    • Results
    • Discussion
    • Appendix: Gulf War Study
      1. References
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link

Abstract

Background:

United States military personnel reported various symptoms after deployment to the Persian Gulf during the 1991 Gulf War. However, the symptoms' long-term prevalence and association with deployment remain controversial.

Objective:

To assess and compare the prevalence of selected medical conditions in a national cohort of deployed and nondeployed Gulf War veterans who were evaluated by direct medical and teledermatologic examinations.

Design:

A cross-sectional prevalence study performed 10 years after the 1991 Gulf War.

Setting:

Veterans were examined at 1 of 16 Veterans Affairs medical centers.

Participants:

Deployed (n = 1061) and nondeployed (n = 1128) veterans of the 1991 Gulf War.

Measurements:

Primary outcome measures included fibromyalgia, the chronic fatigue syndrome, dermatologic conditions, dyspepsia, physical health–related quality of life (Short Form-36 [SF-36]), hypertension, obstructive lung disease, arthralgias, and peripheral neuropathy.

Results:

Of 12 conditions, only 4 conditions were more prevalent among deployed than nondeployed veterans: fibromyalgia (deployed, 2.0%; nondeployed, 1.2%; odds ratio, 2.32 [95% CI, 1.02 to 5.27]); the chronic fatigue syndrome (deployed, 1.6%; nondeployed 0.1%; odds ratio, 40.6 [CI, 10.2 to 161]); dermatologic conditions (deployed, 34.6%; nondeployed, 26.8%; odds ratio, 1.38 [CI, 1.06 to 1.80]), and dyspepsia (deployed, 9.1%; nondeployed, 6.0%; odds ratio, 1.87 [CI, 1.16 to 2.99]). The mean physical component summary score of the SF-36 for deployed and nondeployed veterans was 49.3 and 50.8, respectively.

Limitations:

Relatively low participation rates introduce potential participation bias, and deployment-related illnesses that resolved before the research examination could not, by design, be detected.

Conclusions:

Ten years after the Gulf War, the physical health of deployed and nondeployed veterans is similar. However, Gulf War deployment is associated with an increased risk for fibromyalgia, the chronic fatigue syndrome, skin conditions, dyspepsia, and a clinically insignificant decrease in the SF-36 physical component score.

*For a list of the Gulf War Study Participating Investigators, see the  Appendix.

Editors’ Notes

Context

  • The prevalence and association of medical conditions with deployment to the 1991 Gulf War are controversial.

Contribution

  • This cross-sectional study, performed 10 years after the 1991 Gulf War, compared the prevalence of 12 conditions between 1061 deployed and 1128 nondeployed U.S. veterans. Only fibromyalgia (2% vs. 1.2%), the chronic fatigue syndrome (1.6% vs. 0.1%), skin conditions (34.6% vs. 26.8%), and dyspepsia (9.1% vs. 6.0%) were more common among deployed veterans.

Cautions

  • Short-term conditions that resolved weren't assessed. Fifty-three percent of deployed eligible veterans and 39% of nondeployed eligible veterans participated in the study.

Implications

  • Only a few health conditions seem to be associated with Gulf War deployment.

–The Editors
Approximately 700 000 U.S. servicemen and servicewomen were deployed to the Persian Gulf during the 1991 Gulf War. Although only 200 U.S. combat-related deaths occurred, many personnel were subjected to various natural and man-made environmental exposures, including sand flies, molds, infectious agents, vaccines, medical prophylaxis, pesticides, depleted uranium, oil-fire smoke, biological and chemical warfare agents, and psychological stress (1). Within months of their return, many ground-deployed personnel began reporting fatigue, skin rashes, bone and joint pains, symptoms suggestive of the irritable bowel syndrome, cognitive dysfunction, emotional distress, and other symptoms (2-5). Questionnaire surveys of U.S. (6), British (7), and Canadian (8) veterans and more representative veteran cohorts selected from Iowa (9), New England (10), the U.S. Air Force (11), and Great Britain (12) supported individual reports.
In 1995, the U.S. Department of Veterans Affairs funded the National Health Survey of Gulf War Era Veterans and Their Families research project. This study, which compared the health of 15 000 deployed veterans with 15 000 nondeployed veterans through mail and telephone surveys, found that deployed veterans reported a higher prevalence of 29 of 31 self-reported medical conditions and 48 symptoms than nondeployed veterans (13). In our study, we recruited a subset of deployed and nondeployed veterans who participated in the National Health Survey of Gulf War Era Veterans and Their Families for a medical evaluation to assess and compare the long-term prevalence of selected medical conditions in a national cohort of deployed and nondeployed Gulf War veterans.

Methods

Study Population and Recruitment

Recruitment for the National Health Survey of Gulf War Era Veterans and Their Families study has been described elsewhere in detail (13) and is summarized in the Figure. Briefly, the U.S. Department of Defense's Defense Manpower Data Center, Monterey, California, identified the entire cohort of 693 826 troops who were deployed to the Persian Gulf area during the Gulf War and approximately half (800 680 troops) of the nondeployed troops who were in military service between September 1990 and May 1991. A total of 15 000 deployed and 15 000 nondeployed veterans were solicited to participate in the study. To ensure that women, reservists, and National Guard members were adequately represented, the investigators applied a stratified random sampling method to each group so that one fifth of each sample were women (n = 3000), one third were reservists (n = 5000), and approximately one quarter were members of the National Guard (n = 4000).
Figure.

Sample selection flowchart.

For our study, we created a list of potential participants by randomly selecting from the 11 441 deployed and 9476 nondeployed Gulf War veterans who participated in the 1995 study, stratified by deployment status (deployed or not deployed) and region of last known residence at the time of the original survey based on home telephone area code (Figure). We assigned potential participants to the participating Veterans Affairs medical center closest to their home residence. Participating medical centers were in Albuquerque, New Mexico; Baltimore, Maryland; Birmingham, Alabama; Boston, Massachusetts; Cincinnati, Ohio; Hines (Chicago), Illinois; Houston, Texas; Miami, Florida; Minneapolis, Minnesota; New Orleans, Louisiana; New York, New York; Portland, Oregon; Richmond, Virginia; Salt Lake City, Utah; San Diego, California; and St. Louis, Missouri.
We gave each member of the cohort assigned to a medical center a randomly generated number, and the numbers were sequenced in ascending order. We performed 3 recruitment waves of approximately 40 deployed and 40 nondeployed veterans at approximately 8-month intervals at each site, beginning with the veteran who was assigned the lowest number. In each wave, the veteran received a recruitment package that included an introductory letter, a detailed explanation of the purpose and nature of the study, a letter of intent form, and a preaddressed and stamped return envelope. We asked potential veteran participants to sign and return the letter of intent to participate in the study. Veterans who did not respond within a few weeks received a reminder call. To further encourage study participation, we sent nonrespondents a newsletter and a 12-minute videotape that presented a typical clinical examination day and several testimonies of veterans who had already completed the study. Two research contractors (Gallup Organization, Omaha, Nebraska, for the first wave, and Schulman, Ronca & Bucuvalas, Inc., Silver Spring, Maryland, for successive waves) mailed recruitment packages and made reminder follow-up calls. Because of lower participation rates among nondeployed veterans, we solicited an additional 799 nondeployed veterans to obtain groups of equal size.
The signed letter of intent was returned to the Hines Veterans Affairs Cooperative Studies Program Coordinating Center, Hines, Illinois, which forwarded it to the participating Veterans Affairs medical center to which the veteran was assigned. Site personnel then contacted the veteran and scheduled the examination. The research project provided travel, hotel, and per diem costs and an honorarium of $200. The Hines Cooperative Studies Program Human Rights Committee and the institutional review board at each individual site approved the protocol and consent form. Participants gave signed informed consent shortly before the start of the examination.

Data Collection

To assess nonparticipation bias, we obtained previously collected data from deployed and nondeployed participants and nonparticipants, including sociodemographic and military service characteristics in 1991 from the U.S. Department of Defense's Defense Manpower Data Center and sociodemographic and self-reported health data collected by the National Health Survey of Gulf War Era Veterans and Their Families in 1995.
For our study, physicians and research nurses performed medical, neurologic, gynecologic, and psychiatric histories and examinations between 1999 and 2001 by using carefully standardized methods. A research nurse solicited histories of symptoms and illnesses in 8 system categories by using a structured interview. Examinations were followed by laboratory, pulmonary function, nerve conduction, and neuropsychological tests. The average examination time was 12 hours performed over 2 days. In this paper, we report the study's medical outcomes. Other manuscripts will address the psychiatric and neuropsychological results.

Disease Diagnostic Criteria

Fibromyalgia

The diagnosis of fibromyalgia followed the 1990 American College of Rheumatology criteria of diffuse body pain and pain on physical examination on at least 11 of 18 tender points (14).

The Chronic Fatigue Syndrome

The diagnosis of the chronic fatigue syndrome followed the International Chronic Fatigue Syndrome Study Group case definition (15). After data collection was complete, 4 physicians and a psychologist, who were blinded to the participants' deployment status, reviewed medical and psychiatric data on individuals who met the chronic fatigue syndrome inclusion criteria. We identified exclusionary psychiatric disorders by participant responses to the Composite International Diagnostic Interview (CIDI) (16) and self-reported psychiatric diagnoses. We determined exclusionary medical illnesses from history, examination, self-reported diagnoses, and laboratory testing.

Peripheral Neuropathy

The diagnosis of peripheral neuropathy included any idiopathic or unexplained distal sensory, motor, or sensorimotor polyneuropathy based on physical findings, nerve conduction studies, or both. Upper motor neuron findings, alcohol abuse or dependence, HIV or AIDS, hypothyroidism, diabetes, or antineoplastic medications excluded this diagnosis.

Self-Reported Physical Health–Related Quality of Life

We used the physical component score of the Medical Outcomes Study Short Form-36 (SF-36) (17) to provide an overall measure of current self-reported physical health–related quality of life. For the average healthy population, the physical component score was a mean of 50, SD 10.

Dermatologic Conditions

We divided dermatologic conditions a priori into 2 groups. Group 1 conditions were freckles, lentigines, seborrheic keratoses, nevi, moles, cherry hemangiomas, skin tags, and surgical scars detected by research physicians after full-body skin examinations. Group 2 skin diagnoses included all diagnoses that are not included in group 1. A board-certified dermatologist diagnosed these conditions by using teledermatology, at least 2 digital photographs, and the results of a standardized history and physical examination.

Other Illnesses

Dyspepsia criteria included a history or symptoms of dyspepsia (frequent heartburn and recurrent abdominal pain) and use of antacids, H2-blockers, or other medications to treat dyspepsia. Hypertension was defined as blood pressure greater than 140/90 mm Hg or history of hypertension and use of antihypertensive medications. Hepatitis was defined as an alanine aminotransferase level greater than 1.5 times the upper limit of normal. We based the diagnosis of symptomatic arthralgias on report of persistent and clinically significant bone or joint symptoms with or without joint effusion and treatment with anti-inflammatory agents, narcotic pain medications, or nonnarcotic pain medications. Obstructive lung disease was defined as a history of lung disease (asthma, bronchitis, or emphysema) or pulmonary symptoms (wheezing, dyspnea on exertion, or persistent coughing with phlegm) and either the use of bronchodilators or at least 15% improvement in FEV1 after a short-acting bronchodilator. Diabetes was defined as having a fasting glucose level of 6.99 mmol/L or greater (≥126 mg/dL) at the research examination or taking a hypoglycemic medication. Hypothyroidism was defined as having an untreated thyroid-stimulating hormone level of 10.0 mU/mL or greater or taking medication for hypothyroidism. Hyperthyroidism was defined as having an untreated thyroid-stimulating hormone level less than 0.1 mU/mL or taking medication for hyperthyroidism.

Laboratory Tests

The following laboratory tests were performed on all participants: complete urinalysis and blood tests to measure hemoglobin, fasting blood sugar, blood urea nitrogen, creatinine, sodium, potassium, chloride, bicarbonate, calcium, magnesium, phosphate, albumin, globulins, lactic dehydrogenase, alkaline phosphatase, total and fractionated bilirubin, aspartate and alanine aminotransferases, uric acid, total cholesterol, triglycerides, high-density lipoprotein, and thyroid-stimulating hormone levels; total leukocyte, leukocyte differential, and platelet counts; and erythrocyte sedimentation rate.

Data Quality Assurance

An operations manual provided instructions on the conduct of the study for all 16 sites, supplemented by 3 national training meetings and twice-weekly conference calls. We reviewed all data for accuracy and completeness, entered data into a computer database, and periodically checked data for consistency between variables.

Statistical Analyses

We estimated sample sizes a priori. The target sample size of 1000 persons in each group was sufficient to provide an 80% power to detect prevalence differences of 1.8% for fibromyalgia (assumed prevalences among deployed veterans and nondeployed veterans, 2.3% and 0.5%, respectively), 1.6% for the chronic fatigue syndrome (assumed prevalences among deployed veterans and nondeployed veterans, 1.9% and 0.3%, respectively), 1.5% for peripheral neuropathy (assumed prevalences among deployed veterans and nondeployed veterans, 1.7% and 0.2%, respectively), and a mean difference of 1.5, SD 10, for the physical component score of the SF-36.
We performed all analyses while blinded to deployment status. We based analyses of participation bias (Table 1) on data collected in 1991 and 1995; analyses of current health (Tables 2, 3, and 4) are based on data collected by our present study. Analyses labeled as unadjusted accounted for the stratified sampling design (Figure) on the basis of the sampling probabilities of deployment status, sex, and duty type in the 1995 study and the examination rate of the groups in our study. Logistic regression analyses labeled as adjusted incorporated the stratified sampling design and the following covariates: age, sex, race (white vs. other), years of education (<12 years vs. ≥12 years), cigarette history (smoked cigarettes daily for ≥ 1 month during the past 12 months: yes or no), duty type (active vs. reserves or National Guard), service branch (Army or Marines vs. Navy or Air Force), and rank (enlisted vs. officer). We generated the prevalences among deployed and nondeployed veterans in Tables 1 and 2 by using SAS, version 8 (SAS Institute, Inc., Cary, North Carolina). We used the Fisher exact test for comparisons of sociodemographic and military service characteristics and self-reported medical illnesses. We used SUDAAN, release 8.0 (Research Triangle Institute, Research Triangle Park, North Carolina), to obtain population estimates and SEs, odds ratios, and 95% CIs. We based statistical comparisons on the Wald F statistic.

Table 1. Sociodemographic Characteristics in 1991 and Self-Reported Health Characteristics in 1995 of Individuals Who Completed the 1995 Survey according to Their Participation in the Present Study

Table 1. Sociodemographic Characteristics in 1991 and Self-Reported Health Characteristics in 1995 of Individuals Who Completed the 1995 Survey according to Their Participation in the Present Study

Table 2. Sociodemographic and Military Service Characteristics of Deployed and Nondeployed Participants at the Research Examination

Table 2. Sociodemographic and Military Service Characteristics of Deployed and Nondeployed Participants at the Research Examination

Table 3. Population Prevalence of Illnesses or Symptoms Reported by the 1061 Deployed and 1128 Nondeployed Gulf War Veterans Who Participated in the Research Examination

Table 3. Population Prevalence of Illnesses or Symptoms Reported by the 1061 Deployed and 1128 Nondeployed Gulf War Veterans Who Participated in the Research Examination

Table 4. Population Prevalence of Illnesses Present on Clinical Evaluation among the 1061 Deployed and 1128 Nondeployed Gulf War Veterans Who Participated in the Research Examination

Table 4. Population Prevalence of Illnesses Present on Clinical Evaluation among the 1061 Deployed and 1128 Nondeployed Gulf War Veterans Who Participated in the Research Examination

Role of the Funding Source

The Cooperative Studies Program of the U.S. Department of Veterans Affairs, Office of Research and Development, sponsored the study. The study's Executive Committee, composed of the principal investigators and several co-investigators (see the  Appendix), had full access to the data files of the study and were responsible for the study protocol, case report forms, statistical analysis plan, progress of the study, analysis, and reporting of the data, regardless of the study's outcome. The U.S. Department of Veterans Affairs had the opportunity to comment on the manuscript before submission, but the final version was the sole responsibility of the authors.

Results

Participation Rates and Participation Bias

The Figure presents the sample selection scheme for the study. Although the percentages of nondeployed (439 of 2883 [15.2%]) and deployed (255 of 1996 [12.8%]) participants who could not be located were similar, a higher proportion of nondeployed (1316 of 2883 [45.7%]) than deployed (680 of 1996 [34.1%]) veterans who were successfully located declined to participate. Because of the lower participation rate by nondeployed veterans, we sought participation from more nondeployed veterans (n = 2883) than deployed veterans (n = 1996) to attain the minimum recruitment goal of 1000 deployed and nondeployed veteran examinations.
Table 1 evaluates participation bias. Compared with nonparticipants, deployed and nondeployed participants in our study were older and were more likely to be women, white, and in the reserves. In addition, deployed and nondeployed participants in our study were statistically significantly more likely than nonparticipants in 1995 to report a dermatologic condition, numbness or tingling in hands or feet, symptoms suggestive of the chronic fatigue syndrome, arthritis of any kind, and heartburn or indigestion. Only nondeployed participants were statistically significantly more likely than nondeployed nonparticipants to have an officer rank (19.6% vs. 15.4%, respectively) and to report at least 1 clinic or physician visit in the year before 1995 (46.1% vs. 39.5%, respectively). Deployed participants were statistically significantly more likely than deployed nonparticipants to be in the Army (64.6% vs. 55.9%, respectively).

Participant Characteristics

At the research examination, deployed participants were slightly younger (38.9 years vs. 40.7 years; P < 0.01), were less educated (32.5% vs. 42.0% were college graduates or postgraduates; P < 0.01), were less likely to be married (67.4% vs. 72.3%; P < 0.02), and reported a lower annual family income ($46 800 vs. $52 000; P < 0.01) than nondeployed participants. The percentages of deployed and nondeployed veterans still on active military duty did not differ (7.8% vs. 8.5%, respectively; P > 0.2) (Table 2).

Population Prevalence of Self-Reported Illnesses at the Research Examination

For our study, we first compared the prevalence of self-reported illnesses among deployed and nondeployed veterans (Table 3). Unadjusted and adjusted results statistically significantly differed only in the prevalence of self-reported skin rash and the chronic fatigue syndrome. At the examination, 39.8% of deployed veterans reported having a skin rash versus 27.6% of nondeployed veterans (odds ratio, 1.74 [95% CI, 1.35 to 2.23]), and 2.3% of deployed veterans reported the chronic fatigue syndrome versus 0.4% of nondeployed veterans (odds ratio, 5.61 [CI, 1.71 to 18.42]).

Population Prevalence of Illnesses Diagnosed at the Research Examination

Our most important objective was to compare the prevalence of illnesses among deployed and nondeployed veterans on the basis of direct physical and laboratory evaluation (Table 4). The prevalence of the chronic fatigue syndrome was substantially higher among deployed than nondeployed veterans (1.6% vs. 0.1%; odds ratio, 40.6 [CI, 10.2 to 161]). Of the 38 deployed veterans who self-reported the chronic fatigue syndrome at the research examination, only 3 received this diagnosis. Of 8 nondeployed veterans who self-reported the chronic fatigue syndrome, only 2 received this diagnosis (data not shown). Therefore, self-report of the chronic fatigue syndrome among both deployed and nondeployed veterans has low validity.
Deployed veterans received a diagnosis more often than nondeployed veterans with the aggregate variable of 1 or more group 2 skin condition (that is, all dermatologic diagnoses except freckles or lentigines, seborrheic keratoses, nevi or moles, cherry hemangiomas, skin tags, and surgical scars) (34.6% vs. 26.8%; odds ratio, 1.38 [CI, 1.06 to 1.80]) (Table 4). The most common group 2 skin conditions in this veteran cohort were onychomycosis (4.1%), folliculitis (4.0%), tinea pedis (3.5%), acne vulgaris (2.5%), contact dermatitis (2.2%), and seborrheic dermatitis (2.1%). In adjusted analyses of individual group 2 skin conditions, atopic dermatitis (1.2% vs. 0.3%; odds ratio, 8.1 [CI, 2.4 to 27.7]) and verruca vulgaris (1.6% vs. 0.6%; odds ratio, 4.02 [CI, 1.28 to 12.6]) (data not shown) were statistically significantly more commonly diagnosed among deployed than among nondeployed veterans.
Two percent of deployed veterans received a diagnosis of fibromyalgia versus 1.2% of nondeployed veterans (odds ratio, 2.32 [CI, 1.02 to 5.27]), and 9.1% of deployed veterans received a diagnosis of dyspepsia versus 6.0% of nondeployed veterans (odds ratio, 1.87 [CI, 1.16 to 2.99]).
The mean Physical Component Summary score (±SE) of the SF-36 for deployed veterans (49.3 ± 0.42) was statistically significantly lower than that for nondeployed veterans (50.8 ± 0.32) (P < 0.001). The prevalence of physical examination abnormalities did not differ between deployed and nondeployed veterans. Specifically, the prevalence of palpable liver (3.8% deployed vs. 2.8% nondeployed; P > 0.2); palpable spleen (0.1% deployed vs. 0.4% nondeployed; P > 0.2); or cervical, supraclavicular, axillary, epitrochlear, or inguinal lymphadenopathy (prevalence ranged from 0.02% for epitrochlear lymphadenopathy to 2.4% for cervical lymphadenopathy among deployed veterans and from 0.3% for epitrochlear lymphadenopathy to 2.6% for cervical lymphadenopathy among nondeployed veterans) did not differ. In addition, mean values on all 40 laboratory tests were normal among deployed and nondeployed groups and did not statistically significantly differ between deployed and nondeployed except as follows: blood urea nitrogen level (5.03 mmol/L [14.1 mg/dL] vs. 5.18 mmol/L [14.5 mg/dL]; P = 0.04), magnesium level (0.81 mmol/L [1.95 mg/dL] vs. 0.82 mmol/L [1.98 mg/dL]; P = 0.003), prevalence of 2+ or greater proteinuria (1.04% vs. 0.45%; P = 0.02), and leukocytes on urinalysis (18.0% vs. 15.8%; P = 0.05).

Discussion

One decade after the 1991 Gulf War, our study compared the medical health of a national cross-section of U.S. veterans who were deployed to the Persian Gulf with a control group of nondeployed veterans. Among the study's primary outcomes, fibromyalgia and the chronic fatigue syndrome were significantly more common among deployed than nondeployed veterans. Deployed veterans also demonstrated a higher prevalence of dyspepsia and skin conditions (particularly atopic dermatitis and verruca vulgaris) than nondeployed veterans. The small decrease of 1.53 in the mean self-assessed physical health–related quality of life score of the SF-36 is not clinically important (18). The differences in blood urea nitrogen level, magnesium level, prevalence of proteinuria, and leukocytes on urine examination were small and were not associated with diagnosable disease. We previously reported that detailed analyses of neurologic (19) and pulmonary (20) data collected from this cohort did not demonstrate differences between deployed and nondeployed veterans.
Although we made extraordinary recruitment efforts by using informational mailings, telephone calls, and a videotape, only 53% of eligible deployed and 39% of eligible nondeployed veterans participated. Nevertheless, nonparticipation bias is unlikely to explain our results because nonparticipation bias within the deployed and nondeployed cohorts is similar (Table 1) and because fibromyalgia, the chronic fatigue syndrome, and an aggregate measure of dermatologic conditions are the only medical illnesses that were statistically significantly more common among deployed than nondeployed veterans on examination. If the increased prevalence of these conditions among deployed veterans resulted from nonparticipation bias, we would expect an association between deployment and the diagnosis of many other illnesses. Also, the increased risk among deployed veterans for the chronic fatigue syndrome is 40.6 (CI, 10.2 to 161). This substantial odds ratio is unlikely to be explained entirely by nonparticipation bias. Finally, the mean prevalence of the chronic fatigue syndrome in our nondeployed cohort (0.1%) is similar to that reported for the general U.S. population (5, 21, 22). Of note, the age, education attainment, marital status, and annual income differences between deployed and nondeployed veterans (Table 2) are similar to true differences between deployed and nondeployed service personnel during the Gulf War (23).
Our study's strengths are that 1) the sample was selected independently of veteran medical or psychiatric illness or disability; 2) the stratified sampling method provided enough women and members of the reserves and National Guard to examine the contribution of these subgroups to Gulf War–related illnesses; 3) diagnoses were made with computer-based algorithms developed by researchers who were blinded to the deployment status of participants and were based on a comprehensive health assessment; 4) the extensive clinical assessment permitted the diagnosis of the chronic fatigue syndrome without confounding by psychiatric disorders (21); and 5) because sociodemographic, military service, and self-reported health data were available for all eligible veterans who participated in the 1995 study, we could address the issue of nonparticipation bias by comparing data available from both participants and nonparticipants.
Our study has potential weaknesses. Without a strong theoretical basis for predicting which medical diseases may be caused by the Gulf War experience, data collected focused on the major symptom groups reported by Gulf War veterans (that is, musculoskeletal pain, fatigue, skin rashes, and neuropathic symptoms). The most relevant data to identify differences between deployed and nondeployed veterans may not have been collected. The study's cross-sectional design precludes making cause-and-effect conclusions. Some veterans who were not deployed to the Persian Gulf during the Gulf War may have visited that region between 1992 and the time of the research examination, thereby potentially confounding exposure group assignment, although this is highly unlikely. We did not blindly collect data, which may have introduced observer bias. Although a blinded dermatologist made dermatologic diagnoses by using data from standardized physical examination forms and digital photographs provided by the examining physician, additional or different diagnoses may have been made if the dermatologist had directly examined each participant. The sample size was not sufficient to detect an adverse health outcome resulting from a specific exposure experienced by some veterans or a moderate increase in risk for rare diseases. We did not determine differences in death rates and causes of death among eligible veterans who did not participate in research. The low study participation rate may have biased the results, since the effect of the health status of potential participants on their likelihood to participate is unknown.
Gulf War veterans reported fatigue shortly after their return from the Persian Gulf region in 1991 (2-4, 9, 11, 24-26) and after delays of up to several years (1, 27). Recent studies suggest that the chronic fatigue syndrome among Gulf War veterans may be a different disorder than the sporadically occurring syndrome in the United States (28-30). The mechanisms by which deployment increased the risk for the chronic fatigue syndrome in Gulf War veterans are still unknown. Viscerotropic leishmaniasis from desert sand flies, other oligoparasitic diseases, human herpesvirus (6, 31) Epstein–Barr virus (32), Mycoplasma infections (33), or silicates from the desert sands may precipitate immune activation, abnormally low natural killer cell activity, and impairment of selective lymphocyte functions (34-38). A polyclonal-activating infection or immunization may initiate a sequence of events in genetically susceptible individuals (39-41). Other studies link autonomic and hypothalamic–pituitary axis dysregulation to the chronic fatigue syndrome and suggest physiologic (42, 43) and biological mechanisms (44, 45).
While many dermatologic conditions affected service personnel during deployment to the Persian Gulf (46), several dermatologic conditions are still more common. Perhaps the Persian Gulf region's harsh, desiccating climate or sand silicates themselves precipitated the development of secondary atopic dermatitis. Dermatologic conditions, such as psoriasis, that are known to worsen with stress were not increased statistically among deployed veterans.
The significance of the higher prevalence of dyspepsia among deployed Gulf War veterans is unclear. Of note, similar to combatants of other modern wars (47), deployed veterans in our study reported higher population prevalences of a broad range of gastrointestinal symptoms in the year before the examination compared with nondeployed veterans: nausea (12.5% vs. 8.5%; P = 0.02), appetite loss (6.4% vs. 2.2%; P < 0.001), dysphagia (4.5% vs. 2.2%; P = 0.02), diarrhea (19.1% vs. 12.6%; P = 0.004), constipation (7.9% vs. 4.3%; P = 0.007), bloody stool (6.1% vs. 4.7%; P > 0.2), and vomiting (7.5% vs. 5.3%; P = 0.11).
In summary, 10 years after the 1991 Gulf War, the physical health of deployed veterans is similar to that of nondeployed veterans. However, deployment is associated with an increased risk for fibromyalgia, the chronic fatigue syndrome, certain skin disorders, and dyspepsia. Health care providers should be particularly alert for these conditions when examining veterans who served in the Persian Gulf region during either the 1991 Gulf War or the current conflict. More field studies are needed, perhaps with prospective monitoring of U.S. personnel deployed in the Middle East for the development of these conditions. Continued research, particularly directed at elucidating mechanisms for these associations, is warranted.

Appendix: Gulf War Study

Participating Investigators: Albuquerque, New Mexico: Larry Davis, MD; Donald Salisbury, MD. Baltimore, Maryland: Mohamed S. Al-Ibrahim, MD. Birmingham, Alabama: Warren Blackburn, MD; Mike Everson, PhD. Boston, Massachusetts: Joel Karlinsky, MD; Robin Travers, MD; Jessica Wolfe, PhD. Cincinnati, Ohio: Dewleen Baker, MD; Charles Mendenhall, MD, PhD. Hines, Illinois: John Crayton, MD (Co-Principal Investigator); Robert Tentler, MD. Houston, Texas: Arnold Bernard Gorin, MD. Miami, Florida: Nancy Klimas, MD; Patricia Major, MD. Minneapolis, Minnesota: Maureen Murdoch, MD. New Orleans, Louisiana: Jennifer Vasterling, PhD; Vidyullatha Reddy, MD; Sarala Palliyath, MD. New York, New York: Joseph Leung, MD. Portland, Oregon: Dennis Bourdette, MD. Richmond, Virginia: James K. Schmitt, MD; Deborah Panebianco, MD. Salt Lake City, Utah: Michael J. Battistone, MD. San Diego, California: Arnold Gass, MD. St. Louis, Missouri: Melvin Blanchard, MD; Francis A. Mithen, MD, PhD; Salvador Cruz-Flores, MD; Steven R. Brenner, MD; Becky J. Parks, MD.
Participating Veterans Affairs Medical Centers, Nurse Coordinators, and Research Assistants: Albuquerque, New Mexico: Julia K. Coleman, RN, CS; Jennifer Jones; David Hudson, MA. Baltimore, Maryland: Kathy Schultz; Kristy Duffy, RN; Michelle Janyska, RN; Rosetta Corbett; Walter Williams; Theresa McCrief; Kathleen Yeager. Birmingham, Alabama: Lucille J. Williams, RN; Delois A. Wilson; Brendella Chandler. Boston, Massachusetts: Rachel Rosen, RN; Dorothy Gilroy, RN; Nicole Rossi; Paula Smakowski. Cincinnati, Ohio: Virginia Hedger, RN; Michael Krueger, RN, MSN; Michelle Trudel, RN; Moira Haren, MS, PA-C; Jane Wansky, MSW, LSW; David Reynolds, MA. Hines, Illinois: Clara Sarofim; Jean Panich. Houston, Texas: Beth Coates; Jane Anderson; Crystal McCoy. Miami, Florida: Mack Smith, ARNP; Lottie Cason; Staci Cruess; Debbie Studkey; Minerva Garcia. Minneapolis, Minnesota: Linda Kollman, RN; Marlys Nelson, RN; Marilyn Bader, MA. New Orleans, Louisiana: Todd Doucet; Jane Mielenz, RN; Marva Harris; John Allemand. New York, New York: Elizabeth Herdrich, RN, ANP; Shannon Sedigh; Suzanne Meehan. Portland, Oregon: Lori Danker; Jennifer Marino, RN; Shelley Cooper Hanel; Nicole Jessey; Jennifer Baker. Richmond, Virginia: Judith Craggs, RN; Lori Creasey; Alison Faulk; Nanette Eubanks; Brian Mutchler. Salt Lake City, Utah: Sue Orme, RN; Holly Powers, RN; Melanie Battistone, MS. San Diego, California: Ira Amargo, MSN, CFNP, RN; Jeanette Pettiford, MA. St. Louis, Missouri: Elizabeth Clark, BSN, CRC; Laurie Sumpter; Angelique Zeringue.
Hines Cooperative Studies Program Coordinating Center, Hines, Illinois: William G. Henderson, PhD, Director; Domenic J. Reda, PhD, Acting Director; David J. Semlow, Assistant Director; Tammy Nydam, MA, Project Manager; Renee Alpern, MS, Statistician; Coleen Hall, MBA, MS, Statistician; Weichun Xu, PhD, Statistician; Ken Bukowski, Database Programmer; Mike Kerr, Database Programmer; Rosemarie DeNicolo, Statistical Assistant; Barbara Christine, Statistical Assistant; Tom Sindowski, Statistical Assistant; Sheldena Heard, Statistical Assistant; Victoria Barillas, Statistical Assistant; Joyce Jimenez, Budget Analyst.
Brockton Psychometrics Laboratory, Brockton, Massachusetts: Rosemary Toomey, PhD, Director; Lisa James, Research Assistant; Zachary Warren, Research Assistant.
Chairpersons' Offices: St. Louis, Missouri: Seth Eisen, MD, MSc; Joyce Hunter, RN, MSN, Coordinator. Washington, DC: Han Kang, DrPH; Leila Jackson, PhD, Coordinator; Frances Murphy, MD, MPH, Veterans Affairs Central Office.
Dermatology Reading Laboratory: Hon S. Pak, MD, Fort Sam Houston, Texas; John D. Whited, MD, MHS, Durham, North Carolina; Erin Warshaw, MD, Minneapolis, Minnesota; Mark Welch, MD, Bethesda, Maryland.
Neurology Working Group: Becky J. Parks, MD, Director, St. Louis, Missouri; Larry Davis, MD, Albuquerque, New Mexico; Francis A. Mithen, MD, PhD, St. Louis, Missouri.
Blood Laboratory, Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts: Michael Gaziano, Director; Nancy Pelligrino, Technician; Erin Lopez, Technician.
Consultants: Frederick Wolfe, MD, University of Kansas; Daniel Clauw, MD, Georgetown University; Captain Gregory Gray, MD, Naval Health Research Center; Michael Lyons, PhD, Brockton Psychometrics Laboratory; Frank Weathers, PhD, Auburn University; Marie Walbridge, PhD, Brockton Psychometrics Laboratory; Becky J. Parks, MD, St. Louis Veterans Affairs Medical Center.
Department of Veterans Affairs Headquarters, Washington, DC, Cooperative Studies Program: John Feussner, MD, Chief Research and Development Officer; Steven Berkowitz, PhD, Assistant Director; Joseph Gough, MA, Senior Program Manager.
Executive Committee: Seth A. Eisen, MD, MSc, St. Louis Veterans Affairs Medical Center; Han Kang, DrPH, Environmental Epidemiology Service; Frances Murphy, MD, MPH, VACO; Michael Lyons, PhD, Brockton VAMC; Rosemary Toomey, PhD, Brockton VAMC; William G. Henderson, PhD, Hines CSPCC; Domenic J. Reda, PhD, Hines CSPCC; Captain Gregory Gray, MD, Naval Health Research Center; Melvin Blanchard, MD, St. Louis Veterans Affairs Medical Center; Michael J. Battistone, MD, Salt Lake City Veterans Affairs Medical Center.
Data and Safety Monitoring Board: Paul D. Stolley, MD, MPH, University of Maryland; Daniel A. Hoffman, PhD, George Washington University; Timothy Heeren, PhD, Boston University School of Public Health; Genevieve M. Matanoski, MD, DrPH, Johns Hopkins Bloomberg School of Public Health; Leon Gordis, MD, DrPH, Johns Hopkins Bloomberg School of Public Health; George McCabe, PhD, Purdue University; Edward R. Reese Jr., Disabled American Veterans.

References

  1. Presidential Advisory Committee on Gulf War Veterans' Illnesses. Final Report.
    Washington DC
    U.S. Government Printing Office
    1996
  2. Korényi-Both
    AL
    ,  
    Korényi-Both
    AL
    ,  
    Molnár
    AC
    ,  
    Fidelus-Gort
    R
    .  
    Al Eskan disease: Desert Storm pneumonitis.
    Mil Med
    1992
    157
    452
    62
     PubMed
     PubMed
  3. Oster
    CN
    ,  
    Sanford
    JP
    .  
    Febrile illness in a Desert Storm veteran.
    Hosp Pract (Off Ed)
    1992
    27
    145
    8, 151, 155-60
     PubMed
    CrossRef
     PubMed
  4. Magill
    AJ
    ,  
    Grögl
    M
    ,  
    Gasser
    RA
    Jr
    ,  
    Sun
    W
    ,  
    Oster
    CN
    .  
    Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm.
    N Engl J Med
    1993
    328
    1383
    7
     PubMed
    CrossRef
     PubMed
  5. Unexplained illness among Persian Gulf War veterans in an Air National Guard Unit: preliminary report—August 1990-March 1995.
    MMWR Morb Mortal Wkly Rep
    1995
    44
    443
    7
     PubMed
     PubMed
  6. Kipen
    HM
    ,  
    Hallman
    W
    ,  
    Kang
    H
    ,  
    Fiedler
    N
    ,  
    Natelson
    BH
    .  
    Prevalence of chronic fatigue and chemical sensitivities in Gulf Registry Veterans.
    Arch Environ Health
    1999
    54
    313
    8
     PubMed
    CrossRef
     PubMed
  7. Coker
    WJ
    ,  
    Bhatt
    BM
    ,  
    Blatchley
    NF
    ,  
    Graham
    JT
    .  
    Clinical findings for the first 1000 Gulf war veterans in the Ministry of Defence's medical assessment programme.
    BMJ
    1999
    318
    290
    4
     PubMed
    CrossRef
     PubMed
  8. Robinson
    A
    .  
    Veterans worry that unexplained medical problems a legacy of service during Gulf War.
    CMAJ
    1995
    152
    944
    7
     PubMed
     PubMed
  9. Self-reported illness and health status among Gulf War veterans. A population-based study. The Iowa Persian Gulf Study Group.
    JAMA
    1997
    277
    238
    45
     PubMed
    CrossRef
     PubMed
  10. Proctor
    SP
    ,  
    Heeren
    T
    ,  
    White
    RF
    ,  
    Wolfe
    J
    ,  
    Borgos
    MS
    ,  
    Davis
    JD
    ,  
    et al
    Health status of Persian Gulf War veterans: self-reported symptoms, environmental exposures and the effect of stress.
    Int J Epidemiol
    1998
    27
    1000
    10
     PubMed
    CrossRef
     PubMed
  11. Fukuda
    K
    ,  
    Nisenbaum
    R
    ,  
    Stewart
    G
    ,  
    Thompson
    WW
    ,  
    Robin
    L
    ,  
    Washko
    RM
    ,  
    et al
    Chronic multisymptom illness affecting Air Force veterans of the Gulf War.
    JAMA
    1998
    280
    981
    8
     PubMed
    CrossRef
     PubMed
  12. Unwin
    C
    ,  
    Blatchley
    N
    ,  
    Coker
    W
    ,  
    Ferry
    S
    ,  
    Hotopf
    M
    ,  
    Hull
    L
    ,  
    et al
    Health of UK servicemen who served in Persian Gulf War.
    Lancet
    1999
    353
    169
    78
     PubMed
    CrossRef
     PubMed
  13. Kang
    HK
    ,  
    Mahan
    CM
    ,  
    Lee
    KY
    ,  
    Magee
    CA
    ,  
    Murphy
    FM
    .  
    Illnesses among United States veterans of the Gulf War: a population-based survey of 30,000 veterans.
    J Occup Environ Med
    2000
    42
    491
    501
     PubMed
    CrossRef
     PubMed
  14. Wolfe
    F
    ,  
    Smythe
    HA
    ,  
    Yunus
    MB
    ,  
    Bennett
    RM
    ,  
    Bombardier
    C
    ,  
    Goldenberg
    DL
    ,  
    et al
    The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.
    Arthritis Rheum
    1990
    33
    160
    72
     PubMed
    CrossRef
     PubMed
  15. Fukuda
    K
    ,  
    Straus
    SE
    ,  
    Hickie
    I
    ,  
    Sharpe
    MC
    ,  
    Dobbins
    JG
    ,  
    Komaroff
    A
    .  
    The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.
    Ann Intern Med
    1994
    121
    953
    9
    CrossRef
     PubMed
  16. Andrews
    G
    ,  
    Peters
    L
    .  
    The psychometric properties of the Composite International Diagnostic Interview.
    Soc Psychiatry Psychiatr Epidemiol
    1998
    33
    80
    8
     PubMed
    CrossRef
     PubMed
  17. Ware
    JE
    Jr
    .  
    SF-36 Health Survey: Manual and Interpretation Guide.
    Boston
    The Health Institute, New England Medical Center Hospitals, Inc.
    1993
  18. Wyrwich
    KW
    ,  
    Tierney
    WM
    ,  
    Wolinsky
    FD
    .  
    Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life.
    J Clin Epidemiol
    1999
    52
    861
    73
     PubMed
    CrossRef
     PubMed
  19. Davis
    LE
    ,  
    Eisen
    SA
    ,  
    Murphy
    FM
    ,  
    Alpern
    R
    ,  
    Parks
    BJ
    ,  
    Blanchard
    M
    ,  
    et al
    Clinical and laboratory assessment of distal peripheral nerves in Gulf War veterans and spouses.
    Neurology
    2004
    63
    1070
    7
     PubMed
    CrossRef
     PubMed
  20. Karlinsky
    JB
    ,  
    Blanchard
    M
    ,  
    Alpern
    R
    ,  
    Eisen
    SA
    ,  
    Kang
    H
    ,  
    Murphy
    FM
    ,  
    et al
    Late prevalence of respiratory symptoms and pulmonary function abnormalities in Gulf War I Veterans.
    Arch Intern Med
    2004
    164
    2488
    91
     PubMed
    CrossRef
     PubMed
  21. Natelson
    BH
    .  
    Chronic fatigue syndrome.
    JAMA
    2001
    285
    2557
    9
     PubMed
    CrossRef
     PubMed
  22. Price
    RK
    ,  
    North
    CS
    ,  
    Wessely
    S
    ,  
    Fraser
    VJ
    .  
    Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community.
    Public Health Rep
    1992
    107
    514
    22
     PubMed
     PubMed
  23. Kang
    HK
    ,  
    Bullman
    TA
    .  
    Mortality among US veterans of the Persian Gulf War: 7-year follow-up.
    Am J Epidemiol
    2001
    154
    399
    405
     PubMed
    CrossRef
     PubMed
  24. Murray-Leisure KA, Daniels MO. Visceral and skin aspects of “Persian Gulf mystery disease” associated with sand exposure in a Pennsylvania military unit. In: Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, 4-7 October 1994, Orlando, Florida. Washington, DC: American Society for Microbiology; 1994.
  25. Murphy
    FM
    ,  
    Kang
    H
    ,  
    Dalager
    NA
    ,  
    Lee
    KY
    ,  
    Allen
    RE
    ,  
    Mather
    SH
    ,  
    et al
    The health status of Gulf War veterans: lessons learned from the Department of Veterans Affairs Health Registry.
    Mil Med
    1999
    164
    327
    31
     PubMed
     PubMed
  26. Kang
    HK
    ,  
    Natelson
    BH
    ,  
    Mahan
    CM
    ,  
    Lee
    KY
    ,  
    Murphy
    FM
    .  
    Post-traumatic stress disorder and chronic fatigue syndrome-like illness among Gulf War veterans: a population-based survey of 30, 000 veterans.
    Am J Epidemiol
    2003
    157
    141
    8
     PubMed
    CrossRef
     PubMed
  27. Magill
    AJ
    ,  
    Grogl
    M
    ,  
    Johnson
    SC
    ,  
    Gasser
    RA
    Jr
    .  
    Visceral infection due to Leishmania tropica in a veteran of Operation Desert Storm who presented 2 years after leaving Saudi Arabia [Letter].
    Clin Infect Dis
    1994
    19
    805
    6
     PubMed
    CrossRef
     PubMed
  28. Kennedy
    G
    ,  
    Abbot
    NC
    ,  
    Spence
    V
    ,  
    Underwood
    C
    ,  
    Belch
    JJ
    .  
    The specificity of the CDC-1994 criteria for chronic fatigue syndrome: comparison of health status in three groups of patients who fulfill the criteria.
    Ann Epidemiol
    2004
    14
    95
    100
     PubMed
    CrossRef
     PubMed
  29. Khan
    F
    ,  
    Kennedy
    G
    ,  
    Spence
    VA
    ,  
    Newton
    DJ
    ,  
    Belch
    JJ
    .  
    Peripheral cholinergic function in humans with chronic fatigue syndrome, Gulf War syndrome and with illness following organophosphate exposure.
    Clin Sci (Lond)
    2004
    106
    183
    9
     PubMed
    CrossRef
     PubMed
  30. Cook
    DB
    ,  
    Nagelkirk
    PR
    ,  
    Peckerman
    A
    ,  
    Poluri
    A
    ,  
    Lamanca
    JJ
    ,  
    Natelson
    BH
    .  
    Perceived exertion in fatiguing illness: Gulf War veterans with chronic fatigue syndrome.
    Med Sci Sports Exerc
    2003
    35
    569
    74
     PubMed
    CrossRef
     PubMed
  31. Buchwald
    D
    ,  
    Cheney
    PR
    ,  
    Peterson
    DL
    ,  
    Henry
    B
    ,  
    Wormsley
    SB
    ,  
    Geiger
    A
    ,  
    et al
    A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection.
    Ann Intern Med
    1992
    116
    103
    13
    CrossRef
     PubMed
  32. Straus SE. Studies of herpesvirus infection in chronic fatigue syndrome. Ciba Found Symp. 1993;173:132-9; discussion 139-45. [PMID: 8387907]
  33. Endresen
    GK
    .  
    Mycoplasma blood infection in chronic fatigue and fibromyalgia syndromes.
    Rheumatol Int
    2003
    23
    211
    5
     PubMed
    CrossRef
     PubMed
  34. Korényi-Both
    AL
    ,  
    Korényi-Both
    AL
    ,  
    Juncer
    DJ
    .  
    Al Eskan disease: Persian Gulf syndrome.
    Mil Med
    1997
    162
    1
    13
     PubMed
     PubMed
  35. Klimas
    NG
    ,  
    Salvato
    FR
    ,  
    Morgan
    R
    ,  
    Fletcher
    MA
    .  
    Immunologic abnormalities in chronic fatigue syndrome.
    J Clin Microbiol
    1990
    28
    1403
    10
     PubMed
     PubMed
  36. Landay
    AL
    ,  
    Jessop
    C
    ,  
    Lennette
    ET
    ,  
    Levy
    JA
    .  
    Chronic fatigue syndrome: clinical condition associated with immune activation.
    Lancet
    1991
    338
    707
    12
     PubMed
    CrossRef
     PubMed
  37. Straus
    SE
    ,  
    Fritz
    S
    ,  
    Dale
    JK
    ,  
    Gould
    B
    ,  
    Strober
    W
    .  
    Lymphocyte phenotype and function in the chronic fatigue syndrome.
    J Clin Immunol
    1993
    13
    30
    40
     PubMed
    CrossRef
     PubMed
  38. Nicholson
    GL
    ,  
    Nicolson
    NL
    .  
    Diagnosis and treatment of mycoplasmal infections in Persian Gulf War illness-CFIDS patients.
    International Journal of Occupational Medicine, Immunology, and Toxicology
    1996
    5
    69
    78
  39. Keller
    RH
    ,  
    Lane
    JL
    ,  
    Klimas
    N
    ,  
    Reiter
    WM
    ,  
    Fletcher
    MA
    ,  
    van Riel
    F
    ,  
    et al
    Association between HLA class II antigens and the chronic fatigue immune dysfunction syndrome.
    Clin Infect Dis
    1994
    18
    S154
    6
     PubMed
    CrossRef
     PubMed
  40. Hickie
    IB
    ,  
    Bansal
    AS
    ,  
    Kirk
    KM
    ,  
    Lloyd
    AR
    ,  
    Martin
    NG
    .  
    A twin study of the etiology of prolonged fatigue and immune activation.
    Twin Res
    2001
    4
    94
    102
     PubMed
    CrossRef
     PubMed
  41. Buchwald
    D
    ,  
    Herrell
    R
    ,  
    Ashton
    S
    ,  
    Belcourt
    M
    ,  
    Schmaling
    K
    ,  
    Sullivan
    P
    ,  
    et al
    A twin study of chronic fatigue.
    Psychosom Med
    2001
    63
    936
    43
     PubMed
    CrossRef
     PubMed
  42. Naschitz
    JE
    ,  
    Sabo
    E
    ,  
    Naschitz
    S
    ,  
    Shaviv
    N
    ,  
    Rosner
    I
    ,  
    Rozenbaum
    M
    ,  
    et al
    Hemodynamic instability in chronic fatigue syndrome: indices and diagnostic significance.
    Semin Arthritis Rheum
    2001
    31
    199
    208
     PubMed
    CrossRef
     PubMed
  43. Demitrack
    MA
    ,  
    Dale
    JK
    ,  
    Straus
    SE
    ,  
    Laue
    L
    ,  
    Listwak
    SJ
    ,  
    Kruesi
    MJ
    ,  
    et al
    Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    J Clin Endocrinol Metab
    1991
    73
    1224
    34
     PubMed
    CrossRef
     PubMed
  44. Visser
    J
    ,  
    Graffelman
    W
    ,  
    Blauw
    B
    ,  
    Haspels
    I
    ,  
    Lentjes
    E
    ,  
    de Kloet
    ER
    ,  
    et al
    LPS-induced IL-10 production in whole blood cultures from chronic fatigue syndrome patients is increased but supersensitive to inhibition by dexamethasone.
    J Neuroimmunol
    2001
    119
    343
    9
     PubMed
    CrossRef
     PubMed
  45. Patarca-Montero
    R
    ,  
    Antoni
    M
    ,  
    Fletcher
    MA
    ,  
    Klimas
    NG
    .  
    Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors.
    Appl Neuropsychol
    2001
    8
    51
    64
     PubMed
    CrossRef
     PubMed
  46. Oumeish
    OY
    ,  
    Oumeish
    I
    ,  
    Parish
    JL
    .  
    Gulf War syndrome.
    Clin Dermatol
    2002
    20
    401
    12
     PubMed
    CrossRef
     PubMed
  47. Jones
    E
    ,  
    Hodgins-Vermaas
    R
    ,  
    McCartney
    H
    ,  
    Everitt
    B
    ,  
    Beech
    C
    ,  
    Poynter
    D
    ,  
    et al
    Post-combat syndromes from the Boer war to the Gulf war: a cluster analysis of their nature and attribution.
    BMJ
    2002
    324
    321
    4
     PubMed
    CrossRef
     PubMed
Figure.

Sample selection flowchart.

Table 1. Sociodemographic Characteristics in 1991 and Self-Reported Health Characteristics in 1995 of Individuals Who Completed the 1995 Survey according to Their Participation in the Present Study

Table 1. Sociodemographic Characteristics in 1991 and Self-Reported Health Characteristics in 1995 of Individuals Who Completed the 1995 Survey according to Their Participation in the Present Study

Table 2. Sociodemographic and Military Service Characteristics of Deployed and Nondeployed Participants at the Research Examination

Table 2. Sociodemographic and Military Service Characteristics of Deployed and Nondeployed Participants at the Research Examination

Table 3. Population Prevalence of Illnesses or Symptoms Reported by the 1061 Deployed and 1128 Nondeployed Gulf War Veterans Who Participated in the Research Examination

Table 3. Population Prevalence of Illnesses or Symptoms Reported by the 1061 Deployed and 1128 Nondeployed Gulf War Veterans Who Participated in the Research Examination

Table 4. Population Prevalence of Illnesses Present on Clinical Evaluation among the 1061 Deployed and 1128 Nondeployed Gulf War Veterans Who Participated in the Research Examination

Table 4. Population Prevalence of Illnesses Present on Clinical Evaluation among the 1061 Deployed and 1128 Nondeployed Gulf War Veterans Who Participated in the Research Examination

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


The Health of Gulf War Veterans

This feature is available only to Registered Users

Subscribe/Learn More
Submit a Comment

4 Comments

Peter Manu

Zucker Hillside Hospital

June 8, 2005

Mind-Body Dualism in the Aftermath of War

According to Eisen et al., ten years after the Gulf War, 1.6% of deployed veterans fulfilled criteria for chronic fatigue syndrome (1). In a stark display of mind-body dualism, the authors label chronic fatigue syndrome a "medical outcome", "medical illness" and "medical condition" and postpone the presentation of existing psychiatric and neuropsychological data. The authors' bias avoids the confrontation with the complexity of this illness and thus misinforms the reader.

As defined in 1994, chronic fatigue syndrome is a theoretical construct to be used exclusively for the study of etiology and management of patients with persistent tiredness and other unexplainable complaints (2). The construct was not intended for clinical use and its authors were commendably careful to avoid the implication that the chronic fatigue illness is a "medical" disease or "psychiatric" disorder.

The cartesian separation of soul and matter was a courageous manifesto for the independence of science in an era of religious obscurantism. Today, the dualism is counterproductive as it leads to mechanistic oversimplifications inadequate to explain most suffering. It is therefore important to remember that mysteriously ill Gulf veterans have a very high rate of posttraumatic stress (18%) and somatoform (26%) disorders (3). Posttraumatic stress symptoms and unexplainable somatic complaints were strongly correlated with each other (3,4) and with war zone trauma and severity of depression (4). Symptoms consistent with borderline personality were also produced or exagerated by war-related trauma in the Operation Desert Strom (5). These findings demonstrate once again that somatic complaints do not occur or exist in a mind-less vacuum, but that they are generated, modified and maintained by the interplay of pathology, culture and illness behavior.

1. Eisen SA, Kang HK, Murphy FM, et al. Gulf War veterans' health: Medical evaluation of a U.S. Cohort. Ann Intern Med 2005;142:881-90.

2. Fukuda K, Strauss SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Study Group. Ann Intern Med 1994;121:953-9.

3. Labbate LA, Cardena E, Dimitreva J, et al. Psychiatric syndromes in Persian Gulf veterans: an association of handling dead bodies with somatoform disorders. Psychother Psychosom 1998;67:275-9.

4. Ford JD, Campbell KA, Storzbach D, et al. Posttraumatic stress symptomatology is associated with unexplained illness attributed to Persian Gulf military service. Psychosom Med 2001;63:842-9.

5. Axelrod SR, Morgan CA 3rd, Southwick SM. Symptoms of posttraumatic stress disorder and borderline personality in veterans of Operation Desert Storm. Am J Psychiatry 2005;162:270-5.

Conflict of Interest:

None declared

Timothy Lahey

Dartmouth-Hitchcock Medical Center

June 9, 2005

Gulf War Illness: The Gorilla in the Room

Eisen and colleagues described a constellation of illnesses that are more common in veterans who were deployed in the 1991 Gulf War (1). Their discussion, and an accompanying editorial (2), omits discussion of a major potential contributor to the heightened incidence of diseases such as fibromyalgia and chronic fatigue syndrome in returned combatants: psychological trauma. Common sense suggests that the horror of war can be at least a partial explanation for such physical symptoms. That similar symptoms were reported in combatants in other wars lends credence to this theory (2). For the benefit of returned combatants, and for victims of other forms of psychological trauma, it will be important to understand the link between the psychological trauma of war and physical symptoms better.

Timothy Lahey, MD Dartmouth-Hitchcock Medical Center Lebanon, NH

1. Eisen SA, Kang HK, Murphy FM, et al. Gulf War veterans' health: medical evaluation of a U.S. cohort. Ann Intern Med. 2005;142(11):881-90.

2. Komaroff AL. Unexplained suffering in the aftermath of war. Ann Intern Med. 2005;142(11):938-9.

Conflict of Interest:

None declared

Steven R Brenner

Dept. Neurology, Saint Louis Veterans Admin. Med. Center and Dept. Neurology Saint Louis University

June 14, 2005

Parvovirus B19 as cause of Post Gulf War Symptomatology

Gulf war deployment appeared to be associated with an increased risk of fibromyalgia, chronic fatigue syndrome (CFS), skin conditions and dyspepsia.

Although CFS and fibromyalgia may be related to a variety of causes, Parvovirus B19 has been associated with development of chronic fatigue syndrome and may have been significant in the Gulf War region during the 1st Gulf War since there was an epidemic of Parvovirus B19 related aplastic crisis in the region, 48 patients being hospitalized at the Saudi Aramco-Dhahrain Health Center between July 1991 and March, 1992 (1).

Military personnel living in close proximity would facilitate respiratory spread of a transmissible virus such as Parvovirus B19 and involvement of the local population would also be expected.

CFS and arthralgia may follow parvovirus B19 infection, five patients out of 51 with acute B19 infection going on to develop Centers for Disease Control criteria for diagnosis of CFS, however there was no characteristic pattern of B19 markers/autoantibodies in patients with B19 associated chronic fatigue, one patient being negative for anti-B19 IgG at followup (2).

CFS can persist for years after human parvovirus B19 infection, and acute B19 infection is accompanied by raised circulating levels of IL-1b, IL-6, TNF-a and IFN-g and raised circulating levels of TNF-a and IFN-g persist and are accompanied by MCP-1 in patients who develop CFS (3). CFS may be caused by a variety of microbial and other triggers, however CFS triggered by B19 virus is clinically indistinguishable from idiopathic CFS and exhibits similar cytokine abnormalities (3).

Parvovirus may also be associated with skin conditions, since it causes erythema infectiosum in the acute infection. An increased prevalence of parvovirus B19 DNA has been found in systemic sclerosis skin (4).

Parvovirus B19 may be considered in development of post Gulf War symptomatology such as CFS. References: 1. A Mullouh, A Qudah. An epidemic of aplastic crisis cause by human parovirsu B19.

Pediatr Infect Dis J. 1995; 14: 31-4. 2. J Kerr, J Bracewell, I Laint, et. al. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection. J. Rheumatol 2002; 29: 595- 602. 3. J Kerr, D Tyrrell. Cytokines in parvovirus B19 infection as an aid to understanding chronic fatigue syndrome. Curr Pain Headache Rep. 2003; 5: 333-41. 4. T Ohtsuka, S Yamazaki. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin. Br J Dermatol 2004; 150: 1091-5.

Conflict of Interest:

None declared

Jean Eisinger

Hôpital Clémenceau- Unité Infomyalgies

June 29, 2005

Fibromyalgia syndrome/Chronic Fatigue syndrome dualism through War and Peace

In a recent study, Eisen et al. [1] demonstrate increased prevalence of chronic fatigue syndrome [CFS] in deployed 1991 Gulf War veterans (1,6 vs 0,1 % in undeployed or in general population).The authors try to explain the increased risk for CFS, and incidently for dermatologic conditions and dyspepsia in Gulf War syndrome [GWS], without any comment on an other increased prevalence, that of fibromyalgia [FM] : 2 % vs 1,2 %, often considered as a poorly defined CFS-related condition. Some specific comments could have been welcome on : - FM definition, criteria and evaluation [2,3] or mechanisms : some information on bacterial or viral infections and treatments, immunity disorders or influence of toxics in GWS and chronic illness could have been considered even if the same increased prevalence of FM (2-fold) and CFS (10-fold) has been similarly observed in an other population and a quite different situation (women with endometriosis) [4]. - nosology : Fibromyalgia is a defined entity whose diagnosis needs some discriminative and sometimes sophisticated investigations whereas fibromyalgia syndrome [FMS] could indicate variable symptoms and numerous subgroups linked to the fact that fibromyalgia is the usual outcome of several chronic illnesses (evolution from CFS to FM is practically one way). FM or FMS can coexist with other central sensitivity syndromes [2] such as irritable bowel syndrome, migraine, dysmenorrhea, restless legs syndrome, temporo-mandibular pain and dysfunction, myofascial pain syndrome, female urethral syndrome... All these neuroendocrine immune dysfunctions share biological abnormalities and pathophysiological mechanisms. However the dualism FMS/CFS is one more time demonstrated with their percentage increases after Gulf war or other events [1,4]. This is supported by several biological findings (ribonucleases abnormalities observed mainly in CFS, coherent increase of cerebrospinal fluid Nerve Growth Factor /Substance P or blood pyruvate/acyl carnitine [5] in FMS only). The FMS/CFS concept is a comfortable but unclear label that every physician may afford. To use it in absence of occasional co-morbidity would give up fibromyalgia on the Dark Side of the functionnal diseases. Bibliography 1.Eisen SA, Kang HK, Murphy FM, Blanchard MS, Reda DJ, Henderson WG, Toomey R, Jackson LW, Alpern R, Parks BJ, Klimas N, Hall C, Pak HS, Hunter J, Karlinsky J, Battistone MJ, Lyons MJ. Gulf War Veterans' Health: Medical Evaluation of a U.S. Cohort. Annals of Internal Medicine;142(11);881-890, 2005. 2.Yunus MB : fibromyalgia syndrome clinical features and spectrum. Journal of Musculoske Pain;2(3);5-19, 1994. 3.Eisinger J. Evaluation clinique de la fibromyalgie. Rev Med Int;24:237-42, 2003. 4.Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod.;17(10):2715-24, 2002. 5.Eisinger J. Metabolic abnormalities in fibromyalgia. Clinical Bulletin of Myofascial Therapy. 3(1) ; 3-22, 1998.

Conflict of Interest:

None declared

PDF
Not Available
Citations
Citation

Eisen SA, Kang HK, Murphy FM, et al, and the Gulf War Study Participating Investigators*. Gulf War Veterans' Health: Medical Evaluation of a U.S. Cohort. Ann Intern Med. 2005;142:881–890. doi: https://doi.org/10.7326/0003-4819-142-11-200506070-00005

Download citation file:

  • Ris (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2019

×
Permissions

Published: Ann Intern Med. 2005;142(11):881-890.

DOI: 10.7326/0003-4819-142-11-200506070-00005

75 Citations

See Also

Unexplained Suffering in the Aftermath of War
The Health of Gulf War Veterans
View MoreView Less

Related Articles

The Health of Gulf War Veterans
Annals of Internal Medicine; 142 (11): I-22
Can Antibiotics Cure Gulf War Veterans' Illnesses?
Annals of Internal Medicine; 141 (2): I-12
Benefits and Harms of Doxycycline Treatment for Gulf War Veterans' Illnesses: A Randomized, Double-Blind, Placebo-Controlled Trial
Annals of Internal Medicine; 141 (2): 85-94
War Syndromes and Their Evaluation: From the U.S. Civil War to the Persian Gulf War
Annals of Internal Medicine; 125 (5): 398-405
View MoreView Less

Journal Club

In veterans with PTSD, mindfulness-based group therapy reduced symptom severity
Annals of Internal Medicine; 163 (12): JC9
Obstructive sleep apnea in US veterans was associated with increased mortality and morbidity
Annals of Internal Medicine; 163 (6): JC12
Tai chi reduced severity of fibromyalgia symptoms at 24 weeks compared with aerobic exercise
Annals of Internal Medicine; 168 (12): JC70
Review: Pregabalin reduces fibromyalgia pain but increases adverse events
Annals of Internal Medicine; 166 (2): JC2
View MoreView Less

Related Point of Care

Care of Returning Military Personnel
Annals of Internal Medicine; 159 (1): ITC1-1
View MoreView Less

Related Topics

Chronic Fatigue Syndrome/Fibromyalgia
Rheumatology

Chronic Fatigue Syndrome/Fibromyalgia, Rheumatology.

PubMed Articles

European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen's disease and basal cell carcinomas.
J Eur Acad Dermatol Venereol 2019;33(12):2225-2238.
Culinary Medicine Basics and Applications in Medical Education in the United States.
Nestle Nutr Inst Workshop Ser 2019;92():161-170.
View More

Results provided by: PubMed

CME/MOC Activity Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
The Comments Feature Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Latest RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards and Cover

  • Personae (Cover Photo)
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens|Shibboleth|Log In
Annals of Internal Medicine
PURCHASE OPTIONS
Buy This Article|Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×